PCSK9 and diabetes mellitus: Finally, we also bring further evidence to the obesogenic properties of deficiency or KO of the PCSK9 gene, which may lead to other health detriments, notably diabetes, which need to be considered in the context of PCSK9 inhibition medication or future gene editing possibilities.